ATE486860T1 - Phenothiazin-derivat zur wundheilung - Google Patents

Phenothiazin-derivat zur wundheilung

Info

Publication number
ATE486860T1
ATE486860T1 AT05782564T AT05782564T ATE486860T1 AT E486860 T1 ATE486860 T1 AT E486860T1 AT 05782564 T AT05782564 T AT 05782564T AT 05782564 T AT05782564 T AT 05782564T AT E486860 T1 ATE486860 T1 AT E486860T1
Authority
AT
Austria
Prior art keywords
wound healing
phenothiazine derivative
skin
wound site
phenothiazinium compound
Prior art date
Application number
AT05782564T
Other languages
English (en)
Inventor
Stanley Beames Brown
Cassandra Clare O'grady
Original Assignee
Photopharmica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photopharmica Ltd filed Critical Photopharmica Ltd
Application granted granted Critical
Publication of ATE486860T1 publication Critical patent/ATE486860T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/24—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being only condensed with an anthraquinone nucleus in 1-2 or 2-3 position
    • C09B5/44—Azines of the anthracene series
    • C09B5/60—Thiazines; Oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
    • C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system
AT05782564T 2004-09-20 2005-09-14 Phenothiazin-derivat zur wundheilung ATE486860T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0420888A GB0420888D0 (en) 2004-09-20 2004-09-20 Compounds and uses
PCT/GB2005/003536 WO2006032847A1 (en) 2004-09-20 2005-09-14 Wound healing

Publications (1)

Publication Number Publication Date
ATE486860T1 true ATE486860T1 (de) 2010-11-15

Family

ID=33306894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05782564T ATE486860T1 (de) 2004-09-20 2005-09-14 Phenothiazin-derivat zur wundheilung

Country Status (11)

Country Link
US (3) US7407953B2 (de)
EP (1) EP1797053B1 (de)
JP (1) JP5118967B2 (de)
AT (1) ATE486860T1 (de)
CY (1) CY1111177T1 (de)
DE (1) DE602005024590D1 (de)
DK (1) DK1797053T3 (de)
ES (1) ES2358760T3 (de)
GB (1) GB0420888D0 (de)
PT (1) PT1797053E (de)
WO (1) WO2006032847A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113121D0 (en) 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
EP2947145A1 (de) 2005-04-11 2015-11-25 Crealta Pharmaceuticals LLC Variante formen von uratoxidase und verwendung davon
EP2338465A1 (de) 2005-11-09 2011-06-29 Klox Technologies Inc. Zusammensetzungen und Verfahren für Zahnbleichung
US20070255357A1 (en) 2006-04-28 2007-11-01 Ondine International, Ltd. Nasal decolonization of microbes
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
JP5960944B2 (ja) 2006-11-15 2016-08-02 コーダ セラピューティクス， インコーポレイテッド 創傷治癒のための改善された方法および組成物
CN101631780A (zh) * 2007-04-03 2010-01-20 普罗瑟塔生物谐成公司 用于抗病毒治疗的吩噻嗪衍生物
BRPI0801368A8 (pt) * 2008-05-12 2021-03-23 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp processos de estabilização de radicais cátion de compostos fenotiazínicos, formulações cosmecêuticas, usos de compostos fenotiazínicos na preparação de formulações cosmecêuticas e métodos de prevenção de doenças e distúrbios de pele
SG10201703078QA (en) 2008-11-07 2017-05-30 Klox Technologies Inc Combination of an oxidant and a photoactivator for the healing of wounds
US20100166677A1 (en) 2008-12-30 2010-07-01 Avon Products, Inc. Use of Tiliacora Triandra in Cosmetics and Compositions Thereof
KR20120135183A (ko) * 2009-06-25 2012-12-12 코어랩 파트너스, 인코포레이티드 결절성 통풍 치료에서의 요산염 저하 요법 동안의 통풍결절 반응을 평가하는 방법
SG10201408480RA (en) 2009-06-25 2015-02-27 Crealta Pharmaceuticals Llc Methods for preventing or predicting infusion reactions or antibody-mediated loss of response, by monitoring serum uric acid levels during pegylated uricase therapy
KR101908253B1 (ko) 2009-07-17 2018-10-15 클록스 테크놀로지스 인크. 구강 소독 및 구강 질환의 치료를 위한 산화제, 광감제 및 상처 치유제의 조합
US9655840B2 (en) * 2009-12-22 2017-05-23 Rigshospitalet, Copenhagen University Hospital Wound care products
US8785434B2 (en) 2010-04-30 2014-07-22 Prosetta Antiviral Inc. Antiviral compounds
CA2799223C (en) 2010-06-30 2019-02-26 Avon Products, Inc. Compositions and methods for stimulating magp-1 to improve the appearance of skin
WO2012125983A1 (en) 2011-03-17 2012-09-20 Prosetta Antiviral Inc. Antiviral treatments
WO2012145567A1 (en) 2011-04-20 2012-10-26 Prosetta Antiviral Inc. Antiviral compounds
US20120301904A1 (en) 2011-04-26 2012-11-29 Prosetta Antiviral, Inc Multiprotein assemblies
US20130103123A1 (en) 2011-10-14 2013-04-25 Sazzadur Rahman Khan Light-Emitting Devices for Wound Healing
EA201491830A1 (ru) * 2012-04-02 2015-08-31 Хелс Рисёч, Инк. Композиции и способы, включающие средства, стимулирующие толл-подобный рецептор для профилактики и терапии повреждения кожного эпителия
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
CA2884349C (en) 2012-09-14 2019-03-26 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
AU2013341383B2 (en) 2012-11-12 2017-08-24 The Roger B. And Ann K. Mcnamee Trust U/T/A/D Systems and methods for communicating a live event to users using the internet
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
US10272096B2 (en) 2013-06-07 2019-04-30 The Regents Of The University Of California Methods and systems of treating wounds
AU2014286868B2 (en) 2013-07-03 2019-12-19 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US20150065943A1 (en) * 2013-08-27 2015-03-05 Matthew DeBow Method to Accelerate Healing
CA2944201A1 (en) 2014-04-01 2015-10-08 Klox Technologies Inc. Tissue filler compositions and methods of use
US10153510B2 (en) 2014-06-23 2018-12-11 University Of Kentucky Research Foundation Non-aqueous redox flow batteries including 3,7-perfluoroalkylated phenothiazine derivatives
CA2958879A1 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
ES2856841T3 (es) 2014-10-31 2021-09-28 Klox Tech Inc Fibras y medios de tela fotoactivables
WO2023229659A2 (en) * 2021-10-21 2023-11-30 The General Hospital Corporation Photonic antimicrobial wound surface dressing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE488945C (de) * 1924-09-12 1930-01-25 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von Aminoalkylaminosubstitutionsprodukten der Azin-, Oxazin- und Thiazinreihe
WO1993021992A1 (en) 1992-04-30 1993-11-11 Institute Of Dental Surgery Laser treatment
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
JP2001510773A (ja) * 1997-07-28 2001-08-07 ダーマトレイザー テクノロジーズ リミテッド 光線療法に基づく病原体の治療方法及びそれを達成するための組成物
WO2000030630A1 (en) 1998-11-23 2000-06-02 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic for pain relief
CA2358567A1 (en) * 1999-01-08 2000-07-13 David A. Browdie Tissue adhesive for treating vigorously bleeding surfaces
CN1108156C (zh) 1999-03-26 2003-05-14 夏志陶 一种主要用于手术后创口及外伤伤口的长效止痛剂
US6420455B1 (en) * 1999-06-18 2002-07-16 3M Innovative Properties Company Antimicrobial composition containing photosensitizers articles, and methods of use
ES2356983T3 (es) 2000-02-11 2011-04-15 The General Hospital Corporation Unión tisular fotoquímica.
US7073510B2 (en) 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
GB0113121D0 (en) * 2001-05-30 2001-07-18 Univ Leeds Biologically active photosensitisers
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method

Also Published As

Publication number Publication date
ES2358760T3 (es) 2011-05-13
US20090023715A1 (en) 2009-01-22
EP1797053B1 (de) 2010-11-03
DK1797053T3 (da) 2011-02-21
JP2008513424A (ja) 2008-05-01
US7407953B2 (en) 2008-08-05
EP1797053A1 (de) 2007-06-20
CY1111177T1 (el) 2015-06-11
US20110028459A1 (en) 2011-02-03
GB0420888D0 (en) 2004-10-20
PT1797053E (pt) 2011-02-09
DE602005024590D1 (de) 2010-12-16
JP5118967B2 (ja) 2013-01-16
US20070161625A1 (en) 2007-07-12
WO2006032847A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
ATE486860T1 (de) Phenothiazin-derivat zur wundheilung
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
HK1090843A1 (en) Pharmaceutical compositions for healing wounds
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
DK1651161T3 (da) Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
BRPI0519737A2 (pt) composiÇÕes e mÉtodos para promover a cura de feridas e a regeneraÇço de tecidos
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
CY1110889T1 (el) C-αρυλο γλυκοζιτικοι sglt2 αναστολεις και μεθοδος για την παραγωγη τους
DK1565136T3 (da) Sammensætninger for transdermal oxybutynin-terapi
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
SE0301882D0 (sv) New use I
ATE541574T1 (de) Synergistische entzündungshemmende pharmazeutische zusammensetzung zur verwendung zur reduktion von pge2 vermittelter entzuendung
DK1307227T3 (da) Farmaceutiske sammensætninger
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
WO2007030666A3 (en) Medicated skin care preparation for promoting wound healing
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
FR2846239B1 (fr) Composition de cosmetique destinee a blanchir la peau comprenant du senkyunolide a en tant que principe actif
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
ES2422173T3 (es) Composiciones que contienen aecuorina y procedimientos de uso de las mismas
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1797053

Country of ref document: EP